Akari Therapeutics is advancing a novel antibody-drug conjugate (ADC) payload designed to overcome the limitations of existing cancer therapies, with its lead candidate AKTX-101 approaching c

SK Hynix's blockbuster Nasdaq debut is set to give active traders new ways to capitalize on AI-driven semiconductor momentum with the launch of leveraged long and short ETFs tied to the stock

Frontieras is developing patented coal-to-hydrogen and clean fuel technology as U.S. energy policy shifts toward domestic production. With an $850 million flagship facility underway, strong p

Immersed is building a virtual workspace platform that combines software, AI, and wearable hardware, giving investors an opportunity to back its vision for the future of computing while it's

Cytonics is developing a potential first-in-class therapy designed to target the root cause of osteoarthritis, offering investors a chance to participate ahead of a limited-time funding deadl

Goldman Sachs sees a $1.8 trillion AI infrastructure opportunity, and BluSky AI aims to capitalize on it with fast-deploying, AI-focused data centers.

Policy shifts under the Trump administration are fueling a domestic energy resurgence, creating a $2.1T opportunity for Frontieras North America. With patented technology that converts coal i

Immersed is building a next-generation spatial computing platform that combines AR/VR software, AI productivity tools, and its Visor headset to redefine remote work. With 1.5 million users, $

Miso Robotics is positioning itself at the forefront of the fast-food automation boom, leveraging its AI-powered Flippy kitchen robot, strategic acquisitions, major partnerships, and expandin

EnergyX, a lithium technology company backed by General Motors and others, is promoting its pre-July 16 investment round by highlighting growing lithium demand, its extraction technology, maj